Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mesobuthus tamulus concanesis neurotoxin peptides are a diverse group of small, disulfide-bridged proteins found in the venom of the Indian red scorpion (now often classified as Hottentotta tamulus). These toxins are primarily categorized into alpha-toxins, which bind to site 3 of voltage-gated sodium channels to inhibit inactivation, and various potassium channel toxins, such as Tamapin and Butantoxin, which block specific K+ conductance pathways (Bawaskar & Bawaskar, 1998, The Lancet). The synergistic effect of these toxins leads to prolonged depolarization of excitable membranes, triggering a massive 'autonomic storm' characterized by the sudden release of endogenous catecholamines (Gwee et al., 2002, Toxicon). Clinically, exposure to these peptides results in severe envenomation symptoms, including hypertension, cardiac arrhythmias, and life-threatening pulmonary edema. While these neurotoxins are the causative agents of pathology rather than therapeutic targets, they are critical targets for neutralization by polyvalent antivenoms. Furthermore, they serve as high-affinity pharmacological tools in research to map the structure and function of ion channels (Strong et al., 2001, Archives of Biochemistry and Biophysics). Management of their effects often involves the use of the alpha-1 adrenoceptor antagonist Prazosin to counteract the induced sympathetic overactivity.
These peptides act by binding to voltage-gated sodium channels (Nav) to slow inactivation and blocking various potassium channels (K+), leading to persistent depolarization and massive catecholamine release.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mesobuthus tamulus concanesis neurotoxin peptides (MTC neurotoxins).